Grimaldi A, Gonzalez I, Bosquet F, Komajda M
Service de Diabétologie, Hôpital Pitié-Salpêtrière, Paris.
Presse Med. 1990 Mar 24;19(11):519-24.
Diabetic cardiomyopathy appears to be due to "premature ageing" of the myocardium which loses some of its compliance and becomes less sensitive to catecholamines. The condition seems to be severe mainly in those frequent cases where it is associated with hypertensive and/or ischaemic cardiomyopathy. Neuropathic denervation of the heart, usually partial and predominantly affecting the parasympathetic system, might play a part in the myocardial dysfunction. It has been held responsible for sudden death, but its real consequences in diabetic patients remain to be assessed. Coronary artery disease is the most common cardiac complication of diabetes mellitus: it accounts for 50 per cent of deaths among noninsulin-dependent, and 25 per cent among insulin-dependent diabetic subjects. Its incidence does not seem to decline and its severity, notably in women, is demonstrated by a mortality rate that is twice as high as that observed in the non-diabetic population; hence the importance of primary prevention and treatment of risk factors. However, the specificity to abnormal lipid metabolism, notably hypertriglyceridaemia, the potentiation by chronic hyperglycaemia of the harmful effects of arterial hypertension, and the possible responsibility of coagulation disorders and hyperinsulinism are points that have not yet been elucidated. We still do not know whether the objectives to be attained in terms of plasma cholesterol, triglycerides and fibrinogen levels, as well as of blood pressure values, should be different in diabetic and non-diabetic subjects. In any case, the treatment of risk factors should be accompanied by a systematic search for silent ischaemia which is 2 to 3 times more frequent among diabetic patients. Detection of silent ischaemia by electrocardiography during exercise and/or Holter recordings, and by echocardiography and/or thallium scintigraphy should be performed not only in diabetic patients with coronary artery disease but also to those with other risk factors or albuminuria.
糖尿病性心肌病似乎是由于心肌“过早老化”所致,心肌失去了一些顺应性,对儿茶酚胺的敏感性降低。这种情况似乎主要在那些常与高血压性和/或缺血性心肌病相关的病例中较为严重。心脏的神经病变性去神经支配,通常是部分性的,且主要影响副交感神经系统,可能在心肌功能障碍中起作用。它被认为是猝死的原因,但在糖尿病患者中的实际后果仍有待评估。冠状动脉疾病是糖尿病最常见的心脏并发症:在非胰岛素依赖型糖尿病患者中,它占死亡人数的50%,在胰岛素依赖型糖尿病患者中占25%。其发病率似乎并未下降,其严重性,尤其是在女性中,表现为死亡率是非糖尿病人群的两倍;因此,一级预防和危险因素的治疗非常重要。然而,脂质代谢异常,尤其是高甘油三酯血症的特异性、慢性高血糖对动脉高血压有害作用的增强以及凝血障碍和高胰岛素血症可能的作用等问题尚未阐明。我们仍然不知道在血浆胆固醇、甘油三酯和纤维蛋白原水平以及血压值方面要达到的目标在糖尿病患者和非糖尿病患者中是否应该不同。无论如何,在治疗危险因素的同时,应系统地筛查无症状性缺血,这种情况在糖尿病患者中比常人频繁2至3倍。不仅在患有冠状动脉疾病的糖尿病患者中,而且在有其他危险因素或蛋白尿的患者中,都应通过运动时心电图和/或动态心电图记录以及超声心动图和/或铊闪烁显像来检测无症状性缺血。